Product overview
Vaccine type
Meningococcal ACYW-135 (conjugate vaccine)
Commercial Name
Menveo
Manofacturer
GlaxoSmithKline Vaccines S.r.l.
URL
Responsible NRA
European Medicines Agency
Country
Netherlands
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with liquid active component before use
Presentation
Two vial set (active + active)
Number of Doses
1
Diluent
Liquid active component
Route of Administration
Intramuscular
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 14
Secondary Packaging
carton of 10 vials (5 doses) [4.2 x 4.4 x 8.8 cm]
Tertiary Packaging
Shipping box 720 vials (360 doses) [72 secondary cartons] 38.0 x 22.5 x 13.5 cm
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
none
Cold Chain Volume
32.6 cm3/dose (in secondary packaging)